GastroOne

Summary

GastroOne is a medical facility located in Germantown, Tennessee. This center is recognized for care of Ulcerative Colitis, Crohn's Disease, Nonalcoholic Steatohepatitis, Colitis, Hepatitis C and other specialties. GastroOne is involved with conducting 122 clinical trials across 55 conditions. There are 2 research doctors associated with this hospital, such as Ziad Younes and Scott Duncan, MD.

Top PIs

Clinical Trials running at GastroOne

Ulcerative Colitis

Crohn's Disease

Primary Biliary Cirrhosis

Primary Biliary Cholangitis

Crohn's disease

Colitis

RO7790121

for Ulcerative Colitis

This Phase III, multicenter, double-blind, placebo-controlled, treat-through study will evaluate the efficacy and safety of Afimkibart (RO7790121) compared with placebo in participants with moderately to severely active ulcerative colitis (UC).

Recruiting

1 award

Phase 3

3 criteria

RO7790121

for Ulcerative Colitis

This Phase III, multicenter, double-blind, placebo-controlled study will evaluate the efficacy and safety of induction therapy with Afimkibart (RO7790121) compared with placebo in participants with moderately to severely active ulcerative colitis (UC).

Recruiting

1 award

Phase 3

4 criteria

Immunomodulator Strategy

for Inflammatory Bowel Disease

The purpose of this study is to compare the effectiveness and safety of a strategy of switching to an alternative targeted immunomodulator (TIM) therapy to treat to a target of endoscopic remission, versus continuing index TIM in patients with inflammatory bowel disease (IBD) (Crohn's disease or ulcerative colitis \[UC\]) in symptomatic remission with moderate to severe endoscopic inflammation despite optimization of index TIM in a real-world setting.

Recruiting

1 award

N/A